Daily Briefing

3 minute read

Fortune spotlights organizations leading in AI adoption


Fortune recently released its AIQ 75 rankings, which evaluate how well organizations are adopting and scaling AI technologies across different sectors.

Methodology

For the ranking, Fortune expanded upon ServiceNow's Enterprise AI Maturity Index, which provided a framework for assessing AI readiness across organizations, and partnered with ETR to evaluate Fortune 500 companies on their AI implementation.

Between July 10 and Aug. 11, ETR surveyed technology leaders at Fortune 500 companies, asking them to assess the value of their organization's AI investments as well as their impression of how peer companies were adopting AI. A total of 167 responses were included.

The final AIQ ranking was calculated based on a weight average of four component scores:

  1. Self-report score: This score is calculated based on survey responses where respondents reflected on AI implementation at their own company. Questions focused on AI implementation, return on investment, spending, and value.
  2. Peer-report score: This score is calculated based on survey responses where respondents reflected on AI implementation at other companies in their sector. Questions focused on AI implementation, business development, competitive advantage, governance, and more.
  3. Peer-selection score: This score is based on how frequently respondents selected a company in their sector as "most effective" at implementing AI.
  4. AI-Agents Score: This score measures the maturity, realized value, and scale of an organization's AI agent deployment.

For organizations that were included on Fortune's 2025 AIQ 50 list, their previous ranking scores were included as an additional input. Companies without 2025 data received a reweight score from the four components to create their final score. This year, an additional 25 companies were included in the rankings.

"The expansion of the Fortune AIQ list to 75 companies reflects the acceleration of AI adoption across corporate America," said Jeremy Kahn, AI Editor at Fortune. "Companies in every corner of the economy are moving from experimentation to implementation, using AI to improve operations, serve customers, strengthen decision-making, and create durable competitive advantage."

The companies leading the way with AI

The top 10 companies on Fortune's 2026 AIQ 75 were:

  1. JPMorgan Chase
  2. Alphabet
  3. Coca-Cola
  4. Amazon
  5. Nvidia
  6. Mastercard
  7. Visa
  8. Carrier Global
  9. Cleveland Cliffs
  10. Microsoft

Five healthcare companies also made the list for their success with AI:

30. UnitedHealth Group*
31. Elevance Health
36. DaVita
48. Pfizer
75. Thermo Fisher Scientific

"Every company on Fortune AIQ 75 list understands that AI fundamentally transforms business, but people will determine the outcomes. They're redesigning how work gets done and positioning their people close to where the change actually happens," said Jacqui Canney, chief people and AI enablement officer at ServiceNow. "These 75 companies know that as technology moves faster, your competitive edge comes from the people who can read where the business is headed and steer their teams through the shift."

*Advisory Board is a subsidiary of Optum, a division of UnitedHealth Group. All Advisory Board research, expert perspectives, and recommendations remain independent.

(Jacobs, TIME, 9/30; TIME100 Next list, accessed 10/1)


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

RELATED RESOURCES

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece

Email ask@advisory.com to learn more

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This is for members only. Learn more.

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.